Item 9A. Controls and Procedures
ITEM 9A. Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of the Evaluation Date such that the information required to be disclosed by us in our SEC reports (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, and (ii) is accumulated and communicated to HP’s management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
See Management’s Report on Internal Control over Financial Reporting and the Report of Independent Registered Public Accounting Firm on our internal control over financial reporting in Item 8, which are incorporated herein by reference.
Remediation of Previously Reported Material Weakness
As previously reported in the Company’s Annual Report on Form 10-K for fiscal year ended October 31, 2024, we identified a material weakness in internal control over financial reporting. The material weakness resulted from undue reliance on information generated from certain software solutions affecting various financial statement line items as well as net revenue without effectively designed information technology (“IT”) general controls specifically around user access and change management and job schedule monitoring IT operations. This material weakness did not result in any material misstatement of our financial statements. While this material weakness did not result in a material misstatement of our financial statements, there was a reasonable possibility that it could have resulted in a material misstatement in the Company's annual or interim consolidated financial statements that would not be detected. Accordingly, we determined that it constituted a material weakness.
With respect to the material weakness above, management, under the oversight of the Audit Committee, completed the re-design and implementation of IT general controls specific to the impacted software solutions. During the quarter ended October 31, 2025, we completed our testing of the operating effectiveness of internal controls impacted by these remediation efforts and determined the material weakness has been remediated as of October 31, 2025.
Changes in Internal Control over Financial Reporting
Other than the material weakness remediation activities described above, there has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
ITEM 9B. Other Information.
Our directors and officers (as defined in Exchange Act Rule 16a-1(f)) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act. On September 4, 2025 , Alex Cho , our then President, Personal Systems , adopted a written plan for the sale of up to (i) 86,569 shares of our common stock underlying employee stock options; and (ii) 53,221 shares of our common stock underlying performance adjusted restricted stock units, plus any additional shares that vest based on the achievement of the relevant performance criteria. The plan is scheduled to commence on December 8, 2025 and is scheduled to expire on December 11, 2025 , or on any earlier date on which all of the shares have been sold. This plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
ITEM 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
Not Applicable.
102
Table of Contents
PART III
ITEM 10. Directors, Executive Officers and Corporate Governance.
The names of the executive officers of HP and their ages, titles and biographies as of the date hereof are incorporated by reference from Part I, Item 1, above.
The following information is included in HP’s Proxy Statement related to its 2026 Annual Meeting of Stockholders to be filed within 120 days after HP’s fiscal year end of October 31, 2025 (the “Proxy Statement”) and is incorporated herein by reference:
• Information regarding directors of HP who are standing for reelection and any persons nominated to become directors of HP is set forth under “Corporate Governance and Board of Directors—Board Proposal No. 1 Election of Directors.”
• Information regarding HP’s Audit Committee and designated “audit committee financial experts” is set forth under “Corporate Governance and Board of Directors—Board Proposal No. 1 Election of Directors—How We Are Organized—Audit Committee.”
• Information on HP’s code of business conduct and ethics for directors, officers and employees, also known as “Integrity at HP”, is set forth in the section entitled “Code of Conduct” under “Corporate Governance and Board of Directors—Board Proposal No. 1 Election of Directors,” information on HP’s Corporate Governance Guidelines is set forth in the sections entitled “How We Are Selected” and “Director Independence” under “Corporate Governance and Board of Directors—Board Proposal No. 1 Election of Directors,” and information required by Item 405 of Regulation S-K under the Exchange Act is set forth in the section entitled “Delinquent Section 16(a) Reports.”
Insider Trading Policies and Procedures
The Company has insider trading policies and procedures that govern the purchase, sale and other dispositions of its securities by directors, officers, employees and contractors, as well as by the Company itself. We believe these policies and procedures are reasonably designed to promote compliance with insider trading laws, rules and regulations and applicable listing standards. A copy of our Insider Trading Policy is filed with this Annual Report on Form 10-K as Exhibit 19.
ITEM 11. Executive Compensation.
The following information is included in the Proxy Statement and is incorporated herein by reference:
• Information regarding HP’s compensation of its named executive officers is set forth under “Executive Compensation.”
• Information regarding HP’s compensation of its directors is set forth under “Corporate Governance and Board of Directors—Board Proposal No. 1 Election of Directors—How We Are Compensated.”
• The report of HP’s HR and Compensation Committee is set forth under “Executive Compensation—Board Proposal No. 3 Advisory Vote to Approve Executive Compensation—HR and Compensation Committee Report on Executive Compensation.”
ITEM 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The following information is included in the Proxy Statement and is incorporated herein by reference:
• Information regarding security ownership of certain beneficial owners, directors and executive officers is set forth under “Ownership of Our Stock—Common Stock Ownership of Certain Beneficial Owners and Management.”
• Information regarding HP’s equity compensation plans, including both stockholder approved plans and non-stockholder approved plans, is set forth in the section entitled “Equity Compensation Plan Information.”
ITEM 13. Certain Relationships and Related Transactions, and Director Independence.
The following information is included in the Proxy Statement and is incorporated herein by reference:
• Information regarding transactions with related persons is set forth under “Corporate Governance and Board of Directors—Board Proposal No. 1 Election of Directors—Related-Person Transactions Policies and Procedures.”
• Information regarding director independence is set forth in the section entitled “Director Independence” under “Corporate Governance and Board of Directors—Board Proposal No. 1 Election of Directors.”
103
Table of Contents
ITEM 14. Principal Accountant Fees and Services.
Information regarding principal accounting fees and services is set forth under “Audit Matters—Board Proposal No. 2 Ratification of Independent Registered Public Accounting Firm—Principal Accountant Fees and Services” in the Proxy Statement, which information is incorporated herein by reference.
104
Table of Contents
PART IV
ITEM 15. Exhibits and Financial Statement Schedules.
(a) The following documents are filed as part of this report:
1. All Financial Statements:
The following financial statements are filed as part of this report under Item 8—“Financial Statements and Supplementary Data.”
Reports of Independent Registered Public Accounting Firm
47
Management's Report on Internal Control Over Financial Reporting
49
Consolidated Statements of Earnings
50
Consolidated Statements of Comprehensive Income
51
Consolidated Balance Sheets
52
Consolidated Statements of Cash Flows
53
Consolidated Statements of Stockholders' Deficit
54
Notes to Consolidated Financial Statements
55
2. Financial Statement Schedules:
All schedules are omitted as the required information is not applicable or the information is presented in the Consolidated Financial Statements and notes thereto in Item 8 above.
3. Exhibits:
105
Table of Contents
HP INC. AND SUBSIDIARIES
EXHIBIT INDEX
Exhibit
Number Incorporated by Reference
Exhibit Description Form File No. Exhibit(s) Filing Date
2(a) Separation and Distribution Agreement, dated as of October 31, 2015, by and among Hewlett-Packard Company, Hewlett Packard Enterprise Company and the Other Parties Thereto.**
8-K 001-04423 2.1 November 5, 2015
3(a) Registrant’s Restated Certificate of Incorporation .
8-K 001-04423 3.2
April 25, 2024
3(b) Registrant’s Amended and Restated Bylaws.
8-K 001-04423 3.1 June 25, 2025
3(c) Certificate of Designations of Series A Junior Participating Redeemable Preferred Stock of HP Inc. (included in Exhibit 3(a)).
3(d) Certificate of Designations of Series A Junior Participating Preferred Stock of HP Inc. (included in Exhibit 3(a)).
4(a) Indenture, dated June 1, 2000, between the Registrant and The Bank of New York Mellon Trust Company, National Association, as successor in interest to J.P. Morgan Trust Company, National Association (formerly known as Chase Manhattan Bank and Trust Company, National Association), as Trustee.
S-3 333-134327 4.9 June 7, 2006
4(b) Form of Registrant’s 6.000% Global Note due September 15, 2041 and form of related Officers’ Certificate.
8-K 001-04423 4.5 and 4.6
September 19, 2011
4(c) Specimen certificate for the Registrant’s common stock.
8-A/A 001-04423 4.1 June 23, 2006
4(d) Description of HP Inc.’s securities.
10-K 001-04423 4(h)
December 18, 2023
4(e) Indenture, dated June 17, 2020, between HP Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee.
8-K 001-04423 4.1 June 17, 2020
4(f) Form of 3.000% notes due 2027 and related Officers’ Certificate. 8-K 001-04423 4.3 and 4.5
June 17, 2020
4(g) Form of 3.400% notes due 2030 and related Officers’ Certificate. 8-K 001-04423 4.4 and 4.5
June 17, 2020
4(h) First Supplemental Indenture, dated as of June 16, 2021, between the Registrant and The Bank of New York Mellon Trust Company, N.A., as Trustee .
8-K 001-04423 4.2 June 21, 2021
4(i) Form of 1.450% notes due 2026 and 2.650% notes due 2031 (included in Exhibit 4(j)).
4(j) Form of 4.000% notes due 2029 and related Officers’ Certificate.
8-K 001-04423 4.2 and 4.4
March 31, 2022
4(k) Form of 4.200% notes due 2032 and related Officers’ Certificate.
8-K 001-04423 4.3 and 4.4
March 31, 2022
4(l) Form of 4.750% notes due 2028 and related Officers’ Certificate.
8-K 001-04423 4.2 and 4.4
June 21, 2022
4(m) Form of 5.500% notes due 2033 and related Officers’ Certificate.
8-K 001-04423 4.3 and 4.4
June 21, 2022
4(n) Second Supplemental Indenture, dated as of September 1, 2022, between HP Inc. and The Bank of New York Mellon Trust Company, N.A., as Trustee.
8-K 001-04423 4.2 September 7, 2022
4(o) Form of 4.750% notes due 2029 (included in Exhibit 4(o)).
4(p) Third Supplemental Indenture dated April 14, 2025, by and among HP Inc., The Bank of New York Mellon Trust Company, N.A., as first trustee, and U.S. Bank Trust Company, National Association, as successor trustee.
8-K 001-04423 4.1 April 16, 2025
106
Table of Contents
Exhibit
Number Incorporated by Reference
Exhibit Description Form File No. Exhibit(s) Filing Date
4(q) Form of 5.400% notes due 2030 and related Officers’ Certificate. 8-K 001-04423 4.3 and 4.4
April 25, 2025
4(r) Form of 6.100% notes due 2035 and related Officers’ Certificate. 8-K 001-04423 4.3 and 4. 5
April 25, 2025
10(a) Registrant’s Excess Benefit Retirement Plan, amended and restated as of January 1, 2006.*
8-K 001-04423 10.2 September 21, 2006
10(b) Hewlett-Packard Company Cash Account Restoration Plan, amended and restated as of January 1, 2005.*
8-K 001-04423 99.3 November 23, 2005
10(c) First Amendment to the Hewlett-Packard Company Excess Benefit Retirement Plan.*
10-Q 001-04423 10(b)(b)(b) March 10, 2009
10(d) Second Amended and Restated Hewlett-Packard Company 2004 Stock Incentive Plan, as amended effective February 28, 2013.*
8-K 001-04423 10.2 March 21, 2013
10(e) Form of Grant Agreement for grants of non-qualified stock options.*
10-K 001-04423 10(g)(g)(g) December 16, 2015
10(f) Form of Stock Notification and Award Agreement for awards of restricted stock units.*
10-Q
001-04423
10(r)(r)
March 3, 2016
10(g) Registrant’s 2005 Executive Deferred Compensation Plan, amended and restated effective November 1, 2017.*
10-K/A 001-04423 10(n)(n) December 15, 2017
10(h) Registrant’s Severance and Long-Term Incentive Change in Control Plan for Executive Officers, amended and restated effective February 28, 2020.*
10-Q 001-04423 10(p)(p) March 5, 2020
10(i) 2017 Amendment to the Hewlett-Packard Company Cash Account Restoration Plan.*
10-Q 001-04423 10(w)(w) March 2, 2017
10(j) Second Amendment to the Hewlett-Packard Company Excess Benefit Retirement Plan.*
10-Q 001-04423 10(x)(x)
March 2, 2017
10(k)
Form of Grant Agreement for grants of restricted stock units for directors (for use from November 1, 2017).*
10-Q 001-04423 10(e)(e)(e) March 1, 2018
10(l)
Form of Grant Agreement for grants of stock options for directors (for use from November 1, 2017).*
10-Q 001-04423 10(f)(f)(f) March 1, 2018
10(m)
Form of Grant Agreement for grants of restricted stock units (for use from November 1, 2018).*
10-K 001-04423 10(g)(g)(g) December 13, 2018
10(n)
Form of Grant Agreement for grants of restricted stock units for directors (for use from November 1, 2018).*
10-Q 001-04423 10(k)(k)(k) March 5, 2019
10(o)
Form of Grant Agreement for grants of non-qualified stock options.*
10-K 001-04423 10(m)(m)(m) December 12, 2019
10(p)
Form of Retention Grant Agreement for grants of non-qualified stock options.*
10-K 001-04423 10(n)(n)(n) December 12, 2019
10(q)
Form of Grant Agreement for grants of restricted stock units for directors (for use from January 15, 2020).*
10-Q 001-04423 10(n)(n)(n) March 5, 2020
10(r)
Amendment Number One to Second Amended and Restated HP Inc. 2004 Stock Incentive Plan (as amended effective February 28, 2020).*
10-Q 001-04423 10(r)(r)(r) June 5, 2020
10(s)
Amendment Number One to Registrant’s 2005 Executive Deferred Compensation Plan (as amended effective February 28, 2020).*
10-Q 001-04423 10(s)(s)(s) June 5, 2020
10(t)
Amendment Number Two to Second Amended and Restated HP Inc. 2004 Stock Incentive Plan (as amended effective September 21, 2020.*
10-K 001-04423 10(x)(x)(x) December 10, 2020
107
Table of Contents
Exhibit
Number Incorporated by Reference
Exhibit Description Form File No. Exhibit(s) Filing Date
10(u)
Amendment Number Two to Registrant's 2005 Executive Deferred Compensation Plan (as amended effective September 21, 2020).*
10-K 001-04423 10(y)(y)(y) December 10, 2020
10(v)
Form of Grant Agreement for grants of restricted stock units (for use from November 17, 2020).*
10-Q 001-04423 10(x)(x)(x) March 5, 2021
10(w)
Form of Retention Grant Agreement for grants of restricted stock units (for use from November 17, 2020).*
10-Q 001-04423 10(y)(y)(y) March 5, 2021
10(x)
Form of Grant Agreement for grants of performance-contingent non-qualified stock options.*
10-Q 001-04423 10(c)(c)(c)(c) March 5, 2021
10(y)
Form of Grant Agreement for grants of restricted stock units for directors.*
10-Q 001-04423 10(d)(d)(d)(d) March 5, 2021
10(z)
First Amendment to the Registrant’s Severance and Long-Term Incentive Change in Control Plan for Executive Officers, as amended and restated effective February 28, 2020 (as amended effective December 7, 2020)*
10-Q 001-04423 10(e)(e)(e)(e) March 5, 2021
10(a)(a)
Amendment Number Three to Registrant’s 2005 Executive Deferred Compensation Plan (as amended effective November 17, 2020).*
10-Q 001-04423 10(f)(f)(f)(f) March 5, 2021
10(b)(b)
Amendment Number Four to Registrant’s 2005 Executive Deferred Compensation Plan (as amended effective as of April 1, 2021 and December 31, 2021) .*
10-Q 001-04423 10(j)(j)(j) September 3, 2021
10(c)(c)
Form of Grant Agreement for grants of non-qualified stock options.*
10-Q 001-04423 10(l)(l)(l) March 7, 2022
10(d)(d)
Form of Grant Agreement for grants of performance-contingent non-qualified stock options.*
10-Q 001-04423 10(o)(o)(o) March 7, 2022
10(e)(e)
Plantronics, Inc. 2003 Stock Plan, as amended and restated.*
S-8 333-267151 4.4 August 29, 2022
10(f)(f)
Amendment Number One to the Plantronics, Inc. 2003 Stock Plan, as amended and restated.*
S-8 333-267151 4.5 August 29, 2022
10(g)(g)
Amendment Number Five to Registrant’s 2005 Executive Deferred Compensation Plan.*
10-K 001-04423 10(t)(t)(t) December 6, 2022
10(h)(h)
Form of Grant Agreement for grants of restricted stock units (for use from November 1, 2022).*
10-Q 001-04423 10(u)(u)(u) March 1, 2023
10(i)(i)
Form of Retention Grant Agreement for grants of restricted stock units (for use from November 1, 2022).*
10-Q 001-04423 10(v)(v)(v) March 1, 2023
10(j)(j)
Form of Grant Agreement for grants of non-qualified stock options (for use from November 1, 2022).*
10-Q 001-04423 10(w)(w)(w) March 1, 2023
10(k)(k)
Form of Grant Agreement for grants of performance-contingent non-qualified stock options (for use from November 1, 2022).*
10-Q 001-04423 10(z)(z)(z) March 1, 2023
10(l)(l)
Second Amendment to Registrant’s Severance and Long-Term Incentive Change in Control Plan for Executive Officers, as amended and restated effective February 28, 2020, for Performance-Contingent Stock Options generally granted on or after December 7, 2022.*
10-Q 001-04423 10(a)(a)(a)(a) March 1, 2023
10(m)(m)
Form of Grant Agreement for grants of restricted stock units (for Plantronics, Inc. plan).*
10-Q 001-04423 10(b)(b)(b)(b) March 1, 2023
10(n)(n)
Form of Retention Grant Agreement for grants of restricted stock units (for Plantronics, Inc. plan).*
10-Q 001-04423 10(c)(c)(c)(c) March 1, 2023
10(o)(o)
2023 Amendment to the HP Inc. Cash Account Restoration Plan.*
10-Q 001-04423 10(d)(d)(d)(d) May 31, 2023
108
Table of Contents
Exhibit
Number Incorporated by Reference
Exhibit Description Form File No. Exhibit(s) Filing Date
10(p)(p)
Third Amendment to the HP Inc. Excess Benefit Plan.*
10-Q 001-04423 10(e)(e)(e)(e) May 31, 2023
10(q)(q)
Form of Grant Agreement for grants of restricted stock units (for use from November 1, 2023).*
10-Q
001-04423
10(f)(f)(f)(f)
February 28, 2024
10(r)(r)
Form of Retention Grant Agreement for grants of restricted stock units (for use from November 1, 2023).*
10-Q
001-04423
10(g)(g)(g)(g)
February 28, 2024
10(s)(s)
Form of Grant Agreement for grants of performance-adjusted restricted stock units (for use from November 1, 2023).*
10-Q
001-04423
10(j)(j)(j)(j)
February 28, 2024
10(t)(t)
Form of Grant Agreement for grants of restricted stock units (for Plantronics, Inc. plan for use from December 1, 2023).*
10-Q
001-04423
10(k)(k)(k)(k)
February 28, 2024
10(u)(u)
Form of Retention Grant Agreement for grants of restricted stock units (for Plantronics, Inc. plan for use from December 1, 2023).*
10-Q
001-04423
10(l)(l)(l)(l)
February 28, 2024
10(v)(v)
Registrant’s Fourth Amended and Restated 2004 Stock Incentive Plan.*
8-K
001-04423
10.1 April 25, 2024
10(w)(w)
Five-Year Credit Agreement dated August 1, 2024, by and among the Registrant, the lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent.
8-K
001-04423
10.1 August 6, 2024
10(x)(x)
Form of HP Agreement Regarding Confidential Information and Proprietary Developments*
10-K 001-4423 10(h)(h)(h) December 13, 2024
10(y)(y)
Amended Form of Grant Agreement for grants of performance-adjusted restricted stock units (for use from November 1, 2022).*
10-Q
001-04423
10(a)
February 28, 2025
10(z)(z)
Form of Retention Grant Agreement for grants of restricted stock units (for use from November 1, 2024).*†
10(a)(a)(a)
Form of Retention Grant Agreement for grants of performance-adjusted restricted stock units (for use from November 1, 2024).*†
10(b)(b)(b)
H P Inc. 2021 Employee Stock Purchase Plan (as amended on June 11, 2 025) .*†
19 Insider Trading Policy.
10-K 001-4423 19 December 13, 2024
21 Subsidiaries of the Registrant as of October 31, 202 5 . †
23 Consent of Independent Registered Public Accounting Firm.†
24 Power of Attorney (included on the signature page)
31.1 Certification of Chief Executive Offic er pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended . †
31.2 Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended. †
32 Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. ††
97 HP Inc. Mandatory Covered Compensation Recovery Policy.
10-K
001-04423
97 December 18, 2023
109
Table of Contents
Exhibit
Number Incorporated by Reference
Exhibit Description Form File No. Exhibit(s) Filing Date
101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.†
101.SCH Inline XBRL Taxonomy Extension Schema Document.†
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.†
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.†
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document.†
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.†
104 The cover page from the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2025, formatted in Inline XBRL (included within the Exhibit 101 attachments).†
* Indicates management contract or compensatory plan, contract or arrangement.
** Certain schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Registration S-K. A copy of any omitted schedule and/or exhibit will be furnished supplementally to the SEC upon request.
† Filed herewith.
†† Furnished herewith.
The registrant agrees to furnish to the Commission supplementally upon request a copy of (1) any instrument with respect to long-term debt not filed herewith as to which the total amount of securities authorized thereunder does not exceed 10% of the total assets of the registrant and its subsidiaries on a consolidated basis and (2) any omitted schedules to any material agreements set forth above.
110
Table of Contents
ITEM 16. Form 10-K Summary
None.
111
Table of Contents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: December 10, 2025 HP INC.
By: /s/ KAREN L. PARKHILL
Karen L. Parkhill
Chief Financial Officer
112
Table of Contents
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Karen L. Parkhill and Julie Jacobs, or any of them, his or her attorneys-in-fact, for such person in any and all capacities, to sign any amendments to this report and to file the same, with exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that either of said attorneys-in-fact, or substitute or substitutes, may do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
Signature Title(s) Date
/s/ ENRIQUE LORES President and Chief Executive Officer and Director
(Principal Executive Officer) December 10, 2025
Enrique Lores
/s/ KAREN L. PARKHILL
Chief Financial Officer
(Principal Financial Officer) December 10, 2025
Karen L. Parkhill
/s/ MANPREET GREWAL
Global Controller
(Principal Accounting Officer) December 10, 2025
Manpreet Grewal
/s/ CHARLES V. BERGH Director December 10, 2025
Charles V. Bergh
/s/ BRUCE BROUSSARD Director December 10, 2025
Bruce Broussard
/s/ STACY BROWN-PHILPOT Director December 10, 2025
Stacy Brown-Philpot
/s/ STEPHANIE BURNS Director December 10, 2025
Stephanie Burns
/s/ MARY ANNE CITRINO Director December 10, 2025
Mary Anne Citrino
/s/ RICHARD L. CLEMMER Director December 10, 2025
Richard L. Clemmer
/s/ MA. FATIMA DE VERA FRANCISCO
Director December 10, 2025
Ma. Fatima de Vera Francisco
/s/ DAVID MELINE Director December 10, 2025
David Meline
/s/ JUDITH MISCIK Director December 10, 2025
Judith Miscik
/s/GIANLUCA PETTITI
Director December 10, 2025
Gianluca Pettiti
/s/ KIM K.W. RUCKER Director December 10, 2025
Kim K.W. Rucker
/s/ SONGYEE YOON
Director December 10, 2025
Songyee Yoon
113